News
Vaping might be safer than cigarette smoking, but they carry their own health risks. A New Jersey man’s electronic cigarette ...
The number of lung cancer cases in people who have never smoked is increasing. The disease is different from lung cancer ...
Lung cancer remains the world’s deadliest cancer, and cigarette smoke is its chief culprit. Chemicals in tobacco, such as polycyclic aromatic hydrocarbons (PAHs), damage DNA and trigger the mutations ...
6d
NDTV Profit on MSNGlenmark Pharma launches lung cancer treatment drug Tevimbra in IndiaGlenmark Pharmaceuticals on Tuesday said it has launched the lung cancer treatment drug Tevimbra in India, following the ...
During a live event, Neal E. Ready, MD, and participants discussed what factors justify using PD-1 plus CTLA-4 inhibitor and ...
Glenmark Pharmaceuticals launches Tevimbra, a new lung cancer treatment drug, in India. This marks Glenmark's entry into ...
Global Non Small-Cell Lung Cancer Market, by Type The non-small cell lung cancer market grow at a CAGR of around 9.3% from 2021-2031.
Lung cancer trial reports model for faster, leaner, ... Among the 29% of enrolled patients who had squamous cell carcinoma, the HR (95% CI) was 0.82 (0.56-1.22), with p = 0.17.
Glenmark Pharmaceuticals has launched the lung cancer drug Tevimbra in India after approval by the Central Drugs Standard Control Organisation. Developed by global oncology leader BeiGene, now BeOne ...
Glenmark Pharma launches Tevimbra in India to treat lung and esophageal cancer: Our Bureau, Mumbai Tuesday, June 24, 2025, 14:15 Hrs [IST] Glenmark Pharmaceuticals Ltd, a research ...
Eight researchers specializing in adult oncology from Fred Hutch Cancer Center and the University of Washington have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results